VVPR - SLS IBIO and ALDX are among premarket gainers
2024-04-03 08:53:52 ET
More on premarket gainers & stock
- Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie
- Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects
- SELLAS Life Sciences GAAP EPS of -$1.34 misses by $0.24
- Aldeyra gains on plans for AbbVie-partnered eye disease drug
- Seeking Alpha’s Quant Rating on Aldeyra Therapeutics